Evidence map›Paper›PMID 26900242›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2015

Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on prevention.

A Odone, S Visciarelli, T Lalic, F Pezzetti, F Spagnoli, C Pasquarella, G Ferrari, C Signorelli

Open access · bronzeAbstract read
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Emerging and re-emerging infectious disease in otorhinolaryngology.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2018
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A OdoneDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
S VisciarelliDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
T LalicDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
F PezzettiDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
F SpagnoliDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
C PasquarellaDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
G FerrariDipartimento Chirurgico, Struttura Complessa di Otorinolaringoiatria, ASL 5 Spezzino, La Spezia, Italy.
C SignorelliDipartimento di Scienze Biomediche, Biotecnologiche e Traslazionali, Unità di Sanità Pubblica, Università degli Studi di Parma, Italy;
University of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) infection is a recognised causal factor associated with oropharyngeal cancers. The global burden of HPVrelated oropharyngeal cancers is on the increase and is predicted to surpass the burden of cervical cancer in the near future. As evidence is accumulating on the potential effectiveness of an HPV vaccine in controlling the oropharyngeal cancer epidemic; otorhinolaryngologists assume a key role - not only in the diagnosis and treatment of HPV-related cancers - but also in educating and advocating on HPV prevention. We conducted a survey to assess Italian otorhinolaryngologists' knowledge and attitudes regarding HPV infection, HPV-related oropharyngeal diseases and cancers and available prevention measures, including vaccines. This is the first study conducted in Italy and Europe on this topic. A total of 262 Italian otorhinolaryngologists were recruited during the National Conference of the Italian Association of Otorhinolaryngologists. Our results show that Italian otorhinolaryngologists are knowledgeable regarding HPV infection and have a positive attitude towards HPV vaccine. Our findings provide a useful basis to plan, implement and evaluate targeted educational programmes and training. As we show herein, educational programmes and training specifically focusing on HPV are effective in increasing physicians' knowledge and positive attitudes towards prevention; this ultimately contributes to enhance vaccine uptake among patients and the general population. With the overall aim of controlling the burden of HPV-related cancers, resources and efforts should be devoted to promote continuing education among otorhinolaryngologists and the general medical community and to increase awareness on the role of vaccines in prevention of HPV-related cancers. In this context, there is tremendous opportunity for healthcare providers across fields to cooperate and for public health and otorhinolaryngologist communities to join forces and engage in fruitful collaboration.

Indexed as

Health Knowledge, Attitudes, PracticeOtolaryngologyEuropeFemaleHumansItalyNeoplasmsPapillomavirus InfectionsSurveys and QuestionnairesHead and Neck NeoplasmsHuman papillomavirusKnowledgePapillomavirus VaccinesPrimary prevention

Identifiers

PMID26900242
PMCPMC4755048
OpenAlexW2220899075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.